Over 740 million people worldwide suffer from Dry Eye Syndrome, but most of them remain undiagnosed.
A completely non-invasive photobiomodulation technology — the emission of light at a specific wavelength induces endogenous heating of the eyelids. This treatment facilitates the release of the oily component of the tear film from the Meibomian glands, stabilizing the lipid layer and providing immediate relief to the patient.
The therapy involves several mechanisms:
IPL (Intense Pulsed Light)
-
Uses a broad-spectrum light that heats the area around the eyelids through pulses.
-
This heating helps melt and soften the oily secretions in the Meibomian glands, improving their function.
-
IPL can also reduce inflammation and inhibit the growth of bacteria or microbes along the eyelid margins.
LLLT (Low-Level Light Therapy)
-
Uses a gentler, lower-intensity light (often red or near-infrared) that does not significantly heat the tissue.
-
It stimulates cellular activity, improves blood circulation, and supports glandular regeneration.
Advantages
- Symptom relief
- Painless therapy
- No recovery time required
